Literature DB >> 28434692

Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.

Zhuoran Yin1, Divya Raj2, Nasrin Saiepour3, Debby Van Dam4, Nieske Brouwer2, Inge R Holtman2, Bart J L Eggen2, Thomas Möller5, Joseph A Tamm5, Aicha Abdourahman5, Elly M Hol6, Willem Kamphuis7, Thomas A Bayer8, Peter P De Deyn9, Erik Boddeke10.   

Abstract

Alzheimer's disease (AD) is strongly associated with microglia-induced neuroinflammation. Particularly, Aβ plaque-associated microglia take on an "activated" morphology. However, the function and phenotype of these Aβ plaque-associated microglia are not well understood. We show hyperreactivity of Aβ plaque-associated microglia upon systemic inflammation in transgenic AD mouse models (i.e., 5XFAD and APP23). Gene expression profiling of Aβ plaque-associated microglia (major histocompatibility complex II+ microglia) isolated from 5XFAD mice revealed a proinflammatory phenotype. The upregulated genes involved in the biological processes (gene ontology terms) included: "immune response to external stimulus" such as Axl, Cd63, Egr2, and Lgals3, "cell motility", such as Ccl3, Ccl4, Cxcr4, and Sdc3, "cell differentiation", and "system development", such as St14, Trpm1, and Spp1. In human AD tissue with similar Braak stages, expression of phagocytic markers and AD-associated genes, including HLA-DRA, APOE, AXL, TREM2, and TYROBP, was higher in laser-captured early-onset AD (EOAD) plaques than in late-onset AD plaques. Interestingly, the nonplaque parenchyma of both EOAD and late-onset AD brains, the expression of above-mentioned markers were similarly low. Here, we provide evidence that Aβ plaque-associated microglia are hyperreactive in their immune response and phagocytosis in the transgenic AD mice as well as in EOAD brain tissue. We suggest that Aβ plaque-associated microglia are the primary source of neuroinflammation related to AD pathology.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta-amyloid; Early-onset Alzheimer's disease; Late-onset Alzheimer's disease; Microglia; Neurodegeneration; Neuroinflammation

Mesh:

Substances:

Year:  2017        PMID: 28434692     DOI: 10.1016/j.neurobiolaging.2017.03.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  90 in total

1.  Therapeutic potential of Allium Sativum against the Aβ(1-40)-induced oxidative stress and mitochondrial dysfunction in the Wistar rats.

Authors:  Neetu Saini; Monika Kadian; Alka Khera; Aanchal Aggarwal; Anil Kumar
Journal:  Am J Neurodegener Dis       Date:  2021-04-15

Review 2.  Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood.

Authors:  Paula Desplats; Ashley M Gutierrez; Marta C Antonelli; Martin G Frasch
Journal:  Neurosci Biobehav Rev       Date:  2019-11-05       Impact factor: 8.989

Review 3.  Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.

Authors:  Menizibeya O Welcome
Journal:  Neuromolecular Med       Date:  2019-05-21       Impact factor: 3.843

4.  Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain.

Authors:  Devon S Svoboda; M Inmaculada Barrasa; Jian Shu; Rosalie Rietjens; Shupei Zhang; Maya Mitalipova; Peter Berube; Dongdong Fu; Leonard D Shultz; George W Bell; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

5.  Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.

Authors:  Moustafa Gabr; Ashfaq Ur Rehman; Hai-Feng Chen
Journal:  ACS Med Chem Lett       Date:  2020-08-11       Impact factor: 4.345

6.  Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.

Authors:  Alex K Ray; Juwen C DuBois; Ross C Gruber; Hillary M Guzik; Maria E Gulinello; Geoffrey Perumal; Cedric Raine; Lauren Kozakiewicz; Julie Williamson; Bridget Shafit-Zagardo
Journal:  Glia       Date:  2017-09-19       Impact factor: 7.452

Review 7.  Microglia and macrophages in brain homeostasis and disease.

Authors:  Qingyun Li; Ben A Barres
Journal:  Nat Rev Immunol       Date:  2017-11-20       Impact factor: 53.106

Review 8.  Noncoding RNAs in Alzheimer's disease.

Authors:  M Laura Idda; Rachel Munk; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-12       Impact factor: 9.957

9.  Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo.

Authors:  Jonathan Hasselmann; Morgan A Coburn; Whitney England; Dario X Figueroa Velez; Sepideh Kiani Shabestari; Christina H Tu; Amanda McQuade; Mahshad Kolahdouzan; Karla Echeverria; Christel Claes; Taylor Nakayama; Ricardo Azevedo; Nicole G Coufal; Claudia Z Han; Brian J Cummings; Hayk Davtyan; Christopher K Glass; Luke M Healy; Sunil P Gandhi; Robert C Spitale; Mathew Blurton-Jones
Journal:  Neuron       Date:  2019-07-30       Impact factor: 17.173

Review 10.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.